View Older Stories View More Recent Stories

Jun 25, 2020 09:12PM Form 3 Akouos, Inc. For: Jun 25 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 25, 2020 05:02PM Form SC 13D Forma Therapeutics Holdi Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 22, 2020 09:52AM Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AAC
Jun 22, 2020 09:52AM Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AAC
Jun 18, 2020 09:26PM Form 3 Forma Therapeutics Holdi For: Jun 18 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 16, 2020 08:00AM C4 Therapeutics Raises $170 Million Financing to Bring Robust Pipeline of Protein Degraders to Clinical Proof-of-Concept and to Advance Proprietary Platform
Jun 15, 2020 10:10AM Novavax (NVAX) Raises $200M from Private Placement with RA Capital
Jun 15, 2020 10:09AM Novavax to Raise $200 Million from Private Placement with RA Capital
Jun 15, 2020 10:09AM Novavax to Raise $200 Million from Private Placement with RA Capital
Jun 10, 2020 04:16PM Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 4, 2020 08:15PM Everest Medicines Completes US$310 Million Series C Financing
May 29, 2020 08:00AM Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
May 29, 2020 08:00AM Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
May 28, 2020 04:05PM Lyra Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 28, 2020 04:05PM Lyra Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 26, 2020 09:00AM ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
May 26, 2020 08:00AM Vor Biopharma Adds to Leadership Team with Appointment of Chief Financial Officer
May 20, 2020 06:00AM Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing
May 20, 2020 06:00AM Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing
May 15, 2020 04:42PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
May 14, 2020 04:01PM Sutro Biopharma Announces Closing of $98.0 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
May 7, 2020 04:05PM Verastem Oncology Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress
May 6, 2020 07:06AM TG Therapeutics (TGTX) Announces $60M in ATM Offering
May 6, 2020 07:00AM TG Therapeutics Raises Approximately $60 Million in Gross Proceeds Through its At-the-Market Facility
Apr 28, 2020 08:31AM CANbridge Pharmaceuticals Appoints Acting Chief Scientific Officer
Apr 27, 2020 08:30AM Nkarta Therapeutics Appoints Two New Independent Directors
Apr 9, 2020 04:56PM Form SC 13G/A Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 7, 2020 08:00AM Vor Biopharma Appoints Dr. Robert Pietrusko as Chief Regulatory and Quality Officer
Apr 1, 2020 12:06PM iTeos Therapeutics Closes $125 Million Series B2 Financing
Apr 1, 2020 12:06PM iTeos Therapeutics Closes $125 Million Series B2 Financing
Mar 26, 2020 07:00AM SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
Mar 24, 2020 07:30AM Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
Mar 24, 2020 07:30AM Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
Mar 13, 2020 05:19PM Form SC 13D/A Kala Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 11, 2020 08:01PM Form 3 IMARA Inc. For: Mar 11 Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 11, 2020 04:05PM Verastem Oncology Reports Fourth Quarter and Full-Year 2019 Financial Results
Mar 5, 2020 04:32PM Form SC 13G Verastem, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 3, 2020 08:30AM Akouos Closes $105 Million Series B Financing
Feb 28, 2020 06:15AM Verastem (VSTM) Announces $100 Million Private Placement Offering of Common Stock to Premier Life Sciences Investors
Feb 28, 2020 06:00AM Verastem Oncology Announces $100 Million Private Placement Offering of Common Stock to Premier Life Sciences Investors
Feb 27, 2020 12:00PM Biotech Veteran Jean-Paul Mangeolle Joins TeraPore Technologies Board of Directors
Feb 27, 2020 06:00AM First-Ever Four-Year MIGS Pivotal Trial Results Show Hydrus Microstent Significantly Reduces Need for Invasive Surgery and Subsequent Glaucoma Medication
Feb 27, 2020 06:00AM First-Ever Four-Year MIGS Pivotal Trial Results Show Hydrus Microstent Significantly Reduces Need for Invasive Surgery and Subsequent Glaucoma Medication
Feb 18, 2020 08:30AM CANbridge Pharmaceuticals Completes US$98 Million Series D Financing
Feb 15, 2020 01:21AM Form SC 13G/A Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 15, 2020 01:02AM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
Feb 14, 2020 05:41PM Form SC 13G/A scPharmaceuticals Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 05:28PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 05:28PM Form SC 13G RELMADA THERAPEUTICS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 05:24PM Form SC 13G Prevail Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
View More Recent Stories View Older Stories